Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and Australian economic events. Investment markets and key developments over the past week Share markets mostly fell again over the last week, as uncertainty around the timing […]
Matt Painter, Managing Director & CEO, Kalgoorlie Gold Mining (ASX:KAL) is a proven, low-cost gold discoverer with a large portfolio of West Australian projects.
Kalgoorlie Gold Mining (ASX:KAL) – Webinar Presentation Read More »
Duncan Chessell, CEO, Copper Search (ASX:CUS) is targeting world class Copper-Gold deposits within the Gawler Craton of South Australia.
Copper Search (ASX:CUS) – Webinar Presentation Read More »
Su Zhang, CEO, Star Combo Pharma (ASX:S66) is a leading manufacturer and distributor of premium health and natural beauty products, with its high quality development and manufacturing facilities located in Sydney, Australia.
Star Combo Pharma (ASX:S66) – Webinar Presentation Read More »
David Casey, Managing Director & CEO, D3 Energy’s (ASX:D3E) focus is on the exploration and development of the its initial asset, ER315 located in the Free State Province of South Africa.
D3 Energy (ASX:D3E) – Webinar Presentation Read More »
Brookfield, a Canadian investment giant, has set its sights on becoming the foremost player in Australia’s renewable energy sector with a monumental $10 billion bid to acquire France’s Neoen. This move comes six months after a failed attempt to acquire Origin Energy by the Canadian firm. Neoen, boasting a pipeline of projects nearly 10 gigawatts
Brookfield makes bold move to become Australia’s largest renewable energy owner Read More »
After next Thursday, June 7, S&P Global has a seriously hard problem to resolve: does it start thinking about including Nvidia in the Dow, Wall Street’s oldest and most prestigious index, and if they do, which among the 30 companies in it is to be dropped? Being added to the Dow is the ultimate accolade
Will Nvidia join the Dow? Read More »
To register for today’s webinar click here. Telix Pharmaceuticals (ASX:TLX) announces additional positive data from the ProstACT SELECT trial of TLX591. TLX591 is an investigational anti-PSMA1 radio-antibody-drug conjugate (rADC) therapy being developed for the treatment of mCRPC, differentiated by a short two-week dosing regimen. Shares are trading 7.81 per cent higher at $16.97. AVITA Medical
Stocks of the Hour: Telix Pharmaceuticals, AVITA Medical, EZZ Life Science Read More »
The following transcript was AI-generated. Manny Anton: Good morning and welcome to this week’s edition of Winston’s Weekly: covering all things property. I’m Manny Anton, your host for today’s property chat. Winston, welcome back. Winston Sammut: Thank you. Manny Anton: Okay. As usual, let’s start with rates and inflation data movements in the US markets.
Winston’s Weekly: The month in review Read More »
At 11:30am, the S&P/ASX 200 is 0.49 per cent higher at 7,665.70, following a three-day sell-off, driven by broad buying spurred by slightly elevated April inflation data. Meanwhile, in New York, tech stocks declined as US consumer spending slowed, with Salesforce shares dropping 20% on a bleak outlook, while the focus for global markets shifts
ASX up 0.49% at near noon following three-day sell-off Read More »
